Hirofumi Utsumi - Concepedia

Concepedia

Author

Hirofumi Utsumi

Jikei University School of Medicine ORCID

Also Known As

H. Utsumi, HIROFUMI UTSUMI, Hirofumi Utsumi, Utsumi, Hirofumi

64

Publications

5.1K

Citations

20

H-Index

49

Concepts

All Affiliations

Jikei University School of Medicine Kyushu University Kumamoto University National Cancer Center Akita University

HU

About

Hirofumi Utsumi is an author at Jikei University School of Medicine specializing in medicine, pathology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	4K
2	Pathology	7	7	497
3	Cell Biology	6	6	398
4	Immunology	4	4	238
5	Allergy	2	2	98

Hirofumi Utsumi

×

24

Publications

5.1K

Citations

20

H-Index

	Year	Citations
COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS Robert Altman, L Carreras, Rubén Sierra Díaz, Oxford University Research Archive (ORA) (University of Oxford) ThrombosisIschemic StrokeCardiovascular DiseaseMedicineBlood Platelet	1994	3.3K
PRKN-regulated mitophagy and cellular senescence during COPD pathogenesis Jun Araya, Kazuya Tsubouchi, Nahoko Sato, Autophagy	2018	225
Metformin attenuates lung fibrosis development via NOX4 suppression Nahoko Sato, Naoki Takasaka, Masahiro Yoshida, Respiratory Research	2016	223
Soluble Programmed Cell Death Ligand 1 as a Novel Biomarker for Nivolumab Therapy for Non–Small-cell Lung Cancer Yusuke Okuma, Hiroshi Wakui, Hirofumi Utsumi, Clinical Lung Cancer Non–small-cell Lung CancerNivolumab TherapyMedicineImmunologyCell Death	2018	144
Involvement of PARK2-Mediated Mitophagy in Idiopathic Pulmonary Fibrosis Pathogenesis Kenji Kobayashi, Jun Araya, Shunsuke Minagawa, The Journal of Immunology	2016	140
Reliability of Small Biopsy Samples Compared With Resected Specimens for the Determination of Programmed Death-Ligand 1 Expression in Non–Small-Cell Lung Cancer Satoru Kitazono, Yutaka Fujiwara, Koji Tsuta, Clinical Lung Cancer Non–small-cell Lung CancerPrognostic BiomarkersOncologyCancer DetectionMedicine	2015	136
Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy Yusuke Kurita, Jun Araya, Shunsuke Minagawa, Respiratory Research	2017	95
Phase 1 study of galunisertib, a TGF-beta receptor I kinase inhibitor, in Japanese patients with advanced solid tumors Yutaka Fujiwara, Hiroshi Nokihara, Yasuhide Yamada, Cancer Chemotherapy and Pharmacology MedicineMetronomic TherapyPharmacologyCancer GrowthPathology	2015	94
Safety and efficacy of nivolumab and standard chemotherapy drug combination in patients with advanced non-small-cell lung cancer: a four arms phase Ib study Shintaro Kanda, K. Goto, Hideaki Shiraishi, Annals of Oncology	2016	94
Azithromycin attenuates myofibroblast differentiation and lung fibrosis development through proteasomal degradation of NOX4 Kazuya Tsubouchi, Jun Araya, Shunsuke Minagawa, Autophagy Inflammatory Lung DiseaseLung InflammationPathologyPulmonary Alveolar ProteinosisLung Fibrosis Development	2017	89

Page 1